# Belgique – Produits pharmaceutiques – Spécialité pharmaceutique à base de Nintedanib

Acheteur : Healthcare Public Procurement (HeCaPP).  Pays : Belgique.  CPV : 33600000.

Source: QUOTA CÔTE — https://quotacote.com/opportunites/belgique-produits-pharmaceutiques-specialite-pharmaceutique-a-base-de--7aa52965-849e-44c4-ae62-d2e7ec24c3ee
Last checked by QUOTA: 2026-09-15
Methodology: https://quotacote.com/a-propos-des-donnees

## Key facts

- Country: Belgique [FACT]
- Deadline: 2026-09-15 [FACT]
- Last checked by QUOTA: 2026-09-15 [FACT]
- Sector (QUOTA normalisation): Autre [ANALYSIS]
- Summary: QUOTA editorial summary of the source notice [ANALYSIS]

## Entities

- geography: Belgique
- funder: Healthcare Public Procurement (HeCaPP)
- buyer: Healthcare Public Procurement (HeCaPP)

## Limitations

- QUOTA republishes a normalised summary, not the tender documents themselves.
- Commercial details (source dossier, full deadline history, budget) are reserved for subscribers.